Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
June 13, 2019
Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosis
Toru Kimura, James Monslow, Astero Klampatsa, et al.
Cancer Research
|
October 8, 2010
Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor
Yangbing Zhao, Edmund Moon, Carmine Carpenito, et al.
Cancer Research
|
November 4, 2024
Editor's Note: Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
Yangbing Zhao, Edmund Moon, Carmine Carpenito, et al.
Cancer Immunology Research
|
May 6, 2015
Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors
Enxiu Wang, Liang-Chuan Wang, Ching-Yi Tsai, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 15, 2010
Pharmacologic activation of the innate immune system to prevent respiratory viral infections
Guanjun Cheng, Liang-Chuan S Wang, Zvi G Fridlender, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 14, 2010
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions
Daniel H Sterman, Adri Recio, Andrew R Haas, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 7, 2011
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma
Daniel H Sterman, Andrew Haas, Edmund Moon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 18, 2019
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers
Andrew R Haas, Janos L Tanyi, Mark H O'Hara, et al.
JTO Clinical and Research Reports
|
April 8, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study
Jeffrey C Thompson, Charu Aggarwal, Janeline Wong, et al.
Nature Communications
|
July 22, 2021
A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade
Cecile Geuijen, Paul Tacken, Liang-Chuan Wang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
June 13, 2019
Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosis
Toru Kimura, James Monslow, Astero Klampatsa, et al.
Cancer Research
|
October 8, 2010
Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor
Yangbing Zhao, Edmund Moon, Carmine Carpenito, et al.
Cancer Research
|
November 4, 2024
Editor's Note: Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
Yangbing Zhao, Edmund Moon, Carmine Carpenito, et al.
Cancer Immunology Research
|
May 6, 2015
Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors
Enxiu Wang, Liang-Chuan Wang, Ching-Yi Tsai, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 15, 2010
Pharmacologic activation of the innate immune system to prevent respiratory viral infections
Guanjun Cheng, Liang-Chuan S Wang, Zvi G Fridlender, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 14, 2010
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions
Daniel H Sterman, Adri Recio, Andrew R Haas, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 7, 2011
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma
Daniel H Sterman, Andrew Haas, Edmund Moon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 18, 2019
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers
Andrew R Haas, Janos L Tanyi, Mark H O'Hara, et al.
JTO Clinical and Research Reports
|
April 8, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study
Jeffrey C Thompson, Charu Aggarwal, Janeline Wong, et al.
Nature Communications
|
July 22, 2021
A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade
Cecile Geuijen, Paul Tacken, Liang-Chuan Wang, et al.
Page
of 2